Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Entera Bio Ltd. (ENTX)

3.14   -0.05 (-1.57%) 02-28 16:00
Open: 3.14 Pre. Close: 3.19
High: 3.19 Low: 3.14
Volume: 256 Market Cap: 39M
Entera Bio Ltd., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of orally delivered large molecule therapeutics for unmet medical needs. The company's lead product includes the EB612, an oral parathyroid hormone product candidate that has completed a Phase IIa clinical trial for hypoparathyroidism. It is also developing EB613 that has completed Phase I clinical trials for the treatment of osteoporosis and non-union fractures. The company was founded in 2010 and is headquartered in Jerusalem, Israel.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 3.199 - 3.217 3.217 - 3.231
Low: 3.085 - 3.11 3.11 - 3.131
Close: 3.103 - 3.14 3.14 - 3.171

Technical analysis

as of: 2020-02-28 4:28:11 PM
Overall:       
Stoxline posted a NEUTRAL today, downgraded from higher rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 3.97     One year: 4.64
Support: Support1: 3.06    Support2: 2.86
Resistance: Resistance1: 3.40    Resistance2: 3.97
Pivot: 3.18
Moving Average: MA(5): 3.07     MA(20): 3.18
MA(100): 2.56     MA(250): 3.11
MACD: MACD(12,26): 0.06     Signal(9): 0.11
Stochastic oscillator: %K(14,3): 37.92     %D(3): 30.79
RSI: RSI(14): 53.24
52-week: High: 4.56  Low: 1.35  Change(%): -28.6
Average Vol(K): 3-Month: 1445  10-Days: 168

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
ENTX has closed above bottom band by 41.8%. Bollinger Bands are 26% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

2019-11-21
Earnings Scheduled For November 21, 2019
Companies Reporting Before The Bell BJ's Wholesale Club Holdings, Inc. (NYSE: BJ ) is projected to report quarterly earnings at $0.40 per share on revenue of $3.30 billion. Macy's, Inc. (NYSE: M ) is estimated to report quarterly earnings at $0.00 per share on revenue of $5.32 billion. Brady Corporation (NYSE: BRC ) is expected to report quarterly earnings at $0.63 per share on revenue of $293.67 million. Berry Global Group, Inc. (NYSE: BERY ) is estimated to report quarterly earnings at $0.74 per share on revenue of $3.12 billion. Seadrill Limited (NYSE: SDRL ) is expected to report quarterly loss at $2.03 per share on revenue of $326.13 million. Evoqua Water Technologies Corp. (NYSE: AQUA ) is estimated to report quarterly earnings at $0.18 per share on revenue of $386.61 million. Anaplan, Inc. (NYSE: PLAN ) is projected to report quarterly loss at $0.12 per share on revenue of $86.35 million. BrightView Holdings, Inc. (NYSE: BV ) is estimated to report quarterly earnings at $0.42 per share on revenue of $621.36 million.

2019-03-28
Entera Bio Ltd. (ENTX) CEO Phillip Schwartz on Q4 2018 Results - Earnings Call Transcript
No summary available.

Financial Analysis

Growth NA
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability NA
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency NA
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency NA
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NasdaqGS
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 12.15
Shares Float (M) 5.10
% Held by Insiders 36.07
% Held by Institutions 5.90
Shares Short (K) 3
Shares Short P. Month (K)

Stock Financials

EPS -0.860
Book Value (p.s.) 0.330
PEG Ratio
Profit Margin
Operating Margin -1647.00
Return on Assets (ttm) -58.1
Return on Equity (ttm) -121.2
Qtrly Rev. Growth
Gross Profit (p.s.) 0.041
Sales Per Share
EBITDA (p.s.) -0.850
Qtrly Earnings Growth
Operating Cash Flow (M) -8.07
Levered Free Cash Flow (M) -4.22

Stock Valuations

P/E -3.65
P/E Growth Ratio -0.02
P/BV 9.52
P/S 62.80
P/CF -4.73

Dividends & Splits

Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2019 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.